ELIZABETH RESTINO: Open Payments
NPI 1467422501 · DENVER, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,649 in 82 payments from 24 companies in 2025. Trend: 2023 $1,346 · 2024 $1,549 · 2025 $1,649
Food & beverage: $1,474Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $298 |
| Amgen Inc. | 8 | $240 |
| ABBVIE INC. | 16 | $221 |
| Otsuka America Pharmaceutical, Inc. | 5 | $109 |
| Lilly USA, LLC | 5 | $106 |
| PFIZER INC. | 4 | $72 |
| Exact Sciences Corporation | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
Products named: PROLIA, Wegovy, REXULTI, MOUNJARO, VRAYLAR, Rybelsus, UBRELVY, Cologuard Collection Kit.
Industry payments across NC — which companies pay providers there.
